# Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio as prognostic indicators in Pneumocystis jirovecii pneumonia

**Authors:** Fei Yu, Yousheng Ye, Min Shao

PMC · DOI: 10.3389/fmed.2026.1763688 · Frontiers in Medicine · 2026-02-09

## TL;DR

This study shows that a continuously decreasing neutrophil-to-lymphocyte ratio (NLR) is linked to worse survival in patients with Pneumocystis jirovecii pneumonia.

## Contribution

The study introduces the dynamic trajectory of log-transformed NLR as a novel independent prognostic indicator for PJP outcomes.

## Key findings

- Three NLR trajectories were identified: continuously decreasing, stable, and continuously increasing.
- Patients with a continuously decreasing NLR had significantly lower 28-day survival.
- LogNLR trajectory was an independent prognostic factor, while logMLR and logPLR were not.

## Abstract

Pneumocystis jirovecii pneumonia (PJP) remains a life-threatening opportunistic infection with high mortality, particularly among non-HIV immunocompromised patients. Identifying accessible and reliable prognostic biomarkers is of major clinical importance.

To investigate the prognostic value of dynamic changes in the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) among patients with PJP.

A retrospective study of 165 PJP patients was conducted at two tertiary hospitals. Post-diagnostic trajectories of NLR, MLR, and PLR were analyzed using group-based trajectory modeling (GBTM). Associations between these trajectories and 28-day survival were assessed by Cox proportional hazards regression and Kaplan–Meier survival analysis.

Three distinct NLR trajectories were identified: continuously decreasing (15%), stable (68%), and continuously increasing (17%). Patients with continuously decreasing NLR had significantly lower 28-day survival (P < 0.05). The log-transformed NLR (logNLR) trajectory was an independent prognostic factor, whereas logMLR and logPLR were not significantly associated with outcomes.

The temporal trajectory of logNLR is strongly associated with 28-day survival in PJP. A persistently declining logNLR predicts poor prognosis, suggesting its utility in early risk stratification.

## Linked entities

- **Diseases:** Pneumocystis jirovecii pneumonia (MONDO:0019121)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}
- **Diseases:** HIV (MESH:D015658), fungal infection (MESH:D009181), infectious diseases (MESH:D003141), impaired adaptive immunity (MESH:D018489), hematologic diseases (MESH:D006402), tissue diseases (MESH:D003240), bone marrow suppression (MESH:D001855), P. jirovecii (MESH:D016720), infection (MESH:D007239), cough (MESH:D003371), Organ Failure (MESH:D009102), pulmonary infiltrates (MESH:D017254), cytomegalovirus (MESH:D003586), AIDS (MESH:D000163), fever (MESH:D005334), NLR (MESH:D015467), PJP (MESH:D011020), diseases (MESH:D004194), Inflammation (MESH:D007249), diabetes (MESH:D003920), pulmonary conditions (MESH:D008171), opportunistic infection (MESH:D009894), dyspnea (MESH:D004417), IRIS (MESH:D054019)
- **Chemicals:** carbon dioxide (MESH:D002245), trimethoprim-sulfamethoxazole (MESH:D015662), PO2 (MESH:C093415), creatinine (MESH:D003404), carbenicin (-), HCO3- (MESH:D001639), oxygen (MESH:D010100), Lactic acid (MESH:D019344), bilirubin (MESH:D001663)
- **Species:** Homo sapiens (human, species) [taxon 9606], Pneumocystis jirovecii (species) [taxon 42068], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926367/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926367/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926367/full.md

---
Source: https://tomesphere.com/paper/PMC12926367